Low molecular weight heparins: Structural differentiation by spectroscopic and multivariate approaches

Carbohydrate Polymers

Volumn 85, Issue 4, 2011, Pages 903-909

  Lima, Marcelo A ^a   De Farias, Eduardo H C ^a   Rudd, Timothy R ^b   Ebner, Lyvia F ^a   Gesteira, Tarsis F ^a   Mendes, Aline ^a   Bouas, Rodrigo I ^a   Martins, João Roberto M ^a   Hoppensteadt, Debra ^c   Fareed, Jawed ^c   Yates, Edwin A ^b   Sassaki, Guilherme L ^d   Tersariol, Ivarne L S ^a   Nader, Helena B ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^d FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Biosimilar; Circular dichroism; Low molecular weight heparin; Nuclear magnetic resonance; Principal component analysis; Scanning UV

Indexed keywords

ANALYTICAL METHOD; BIOSIMILAR; CIRCULAR DICHROISM; LOW MOLECULAR WEIGHT HEPARIN; LOW-MOLECULAR WEIGHT HEPARINS; MULTIVARIATE APPROACH; STRUCTURAL DIFFERENTIATION;

DICHROISM; MAGNETIC RESONANCE; POLYSACCHARIDES; PRINCIPAL COMPONENT ANALYSIS;

MOLECULAR WEIGHT;

EID: 79956188818     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2011.04.021     Document Type: Article

References (23)

1. A. Bisio, L. De Ambrosi, S. Gonella, M. Guerrini, S. Guglieri, G. Maggia, and G. Torri Preserving the original heparin structure of a novel low molecular weight heparin by gamma-irradiation Arzneimittelforschung 51 10 2001 806 813 (Pubitemid 33001101)
2. B. Casu, P. Oreste, G. Torri, G. Zoppetti, J. Choay, J.C. Lormeau, M. Petitou, and P. Sinay The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studies Biochemical Journal 197 3 1981 599 609 (Pubitemid 12232759)
3. J. Fareed, D. Hoppensteadt, W. Jeske, R. Clarizio, and J.M. Walenga Low molecular weight heparins: a developmental perspective Expert Opinion on Investigational Drugs 6 6 1997 705 733 (Pubitemid 27278219)
4. E. Gray, and B. Mulloy Biosimilar low molecular weight heparin products Journal of Thrombosis and Haemostasis 7 7 2009 1218 1221
5. M. Guerrini, S. Guglieri, A. Naggi, R. Sasisekharan, and G. Torri Low molecular weight heparins: structural differentiation by bidimensional nuclear magnetic resonance spectroscopy Seminars in Thrombosis and Hemostasis 33 5 2007 478 487 (Pubitemid 47105737)
6. M. Guerrini, A. Naggi, S. Guglieri, R. Santarsiero, and G. Torri Complex glycosaminoglycans: profiling substitution patterns by two-dimensional nuclear magnetic resonance spectroscopy Analytical Biochemistry 337 1 2005 35 47 (Pubitemid 40092776)
7. J. Harenberg, A. Kakkar, D. Bergqvist, T. Barrowcliffe, B. Casu, J. Fareed, P. Mismetti, F.A. Ofosu, W. Raake, M. Samama, and S. Schulman Recommendations on biosimilar low-molecular-weight heparins Journal of Thrombosis and Haemostasis 7 7 2009 1222 1225
8. J. Hirsh, T.E. Warkentin, R. Raschke, C. Granger, E.M. Ohman, and J.E. Dalen Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety Chest 114 5 Suppl 1998 489S 510S (Pubitemid 28535777)
9. Hoppensteadt D.I.O. a. F. J. (2006). Basic and clinical differences of heparin and low molecular weight heparin treatment. In L.R. a. H. C. Garg HG. Chemistry and Biology of Heparin and Heparan Sulfate, Elsevier pp. 583-606.
10. D.A. Hoppensteadt, W. Jeske, J. Fareed, and E.W. Bermes Jr. The role of tissue factor pathway inhibitor in the mediation of the antithrombotic actions of heparin and low-molecular-weight heparin Blood Coagul Fibrinolysis 6 Suppl. (1) 1995 S57 64
11. E.A. Johnson, T.B. Kirkwood, Y. Stirling, J.L. Perez-Requejo, G.I. Ingram, D.R. Bangham, and M. Brozovic Four heparin preparations: anti-Xa potentiating effect of heparin after subcutaneous injection Thrombosis and Haemostasis 35 3 1976 586 591
12. Lima, M.A., Rudd, T.R., de Farias, E.H. C., Ebner, L.F., Gesteira, T.F., de Souza, L.M., Mendes, A., Cordula, C.R., Martins, J. o. R. M., Hoppensteadt, D., Fareed, J., Sassaki, G.L., Yates, E.A., Tersariol, I.L. S., Nader, H.B. (2011). A new approach for heparin standardization: combination of scanning UV spectroscopy, nuclear magnetic resonance and principal component analysis. PLoS ONE, 6(1), e15970.
13. Lormeau J.-C., P.M. a. C.J. (1998). Oligosaccharides having anti Xa activity and pharmaceutical compositions containing them. In U. Patente. US.
14. E.R. Morris, D.A. Rees, G.R. Sanderson, and D. Thom Conformation and circular dichroism of uronic acid residues in glycosides and polysaccharides Journal of the Chemical Society, Perkin Transactions 2 13 1975 1418 1425
15. H.B. Nader, C.C. Lopes, H.A. Rocha, E.A. Santos, and C.P. Dietrich Heparins and heparinoids: occurrence, structure and mechanism of antithrombotic and hemorrhagic activities Current Pharmaceutical Design 10 9 2004 951 966 (Pubitemid 38380074)
16. F.A. Ofosu The United States Food and Drugs Administration approves a generic enoxaparin Clinical and Applied Thrombosis/Hemostasis 17 1 2011 5 8
17. Pharmacopoeia, E. (2008). Monograph 01/2008:0828 Heparins, Low-Molecular-mass. pp. 2041-2042).
18. T.R. Rudd, M.A. Skidmore, S.E. Guimond, J. Holman, J.E. Turnbull, R.M. Lauder, D.G. Fernig, and E.A. Yates The potential for circular dichroism as an additional facile and sensitive method of monitoring low-molecular-weight heparins and heparinoids Thrombosis and Haemostasis 102 5 2009 874 878
19. Z. Shriver, M. Sundaram, G. Venkataraman, J. Fareed, R. Linhardt, K. Biemann, and R. Sasisekharan Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin Proceedings of the National Academy of Sciences of the United States of America 97 19 2000 10365 10370
20. G. Viccini, T.R. Martinelli, R.C. Cognialli, R.O. de Faria, E.R. Carbonero, G.L. Sassaki, and D.A. Mitchell Exopolysaccharide from surface-liquid culture of Clonostachys rosea originates from autolysis of the biomass Archives of Microbiology 191 4 2009 369 378
21. C. Viskov, M. Just, V. Laux, P. Mourier, and M. Lorenz Description of the chemical and pharmacological characteristics of a new hemisynthetic ultra-low-molecular-weight heparin, AVE5026 Journal of Thrombosis and Haemostasis 7 7 2009 1143 1151
22. Vismara, E., Pierini, M., Mascellani, G., Liverani, L., Lima, M., Guerrini, M., Torri, G. (2010). Low-molecular-weight heparin from Cu2+ and Fe2+ Fenton type depolymerisation processes. Thrombosis and Haemostasis, 103(3), 613-622.
23. G. Yu, L. LeBrun, N.S. Gunay, D. Hoppensteadt, J.M. Walenga, J. Fareed, and R.J. Linhardt Heparinase I acts on a synthetic heparin pentasaccharide corresponding to the antithrombin III binding site Thrombosis Research 100 6 2000 549 556 (Pubitemid 32056307)